Oxytrex: Phase II data

In a double-blind, 3-week Phase I trial in 362 patients, twice-daily Oxytrex significantly reduced pain intensity compared with placebo, 4 times daily oxycodone and 4 times daily Oxytrex (p<0.001, p=0...